December 2024 – Victor Shengkan Jin Laboratory

Global Pharmaceutical Company Uses Our Genome Editing Technology for Developing Cell Therapy

December 3, 2024 | By Shengkan Jin | Uncategorized

Technology Developed at Rutgers Sublicensed to Global Biopharmaceutical Company

Victor Shengkan Jin Received Edison Patent Award in Biotechnology

December 3, 2024 | By Shengkan Jin | Uncategorized

Victor Shengkan Jin Received Edison Patent Award in Biotechnology